Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (66)

« Back to Publications

OxPhos in adipose tissue macrophages regulated by BTK enhances their M2-like phenotype and confers a systemic immunometabolic benefit in obesity.

Purvis GSD. et al, (2024), Diabetes

FCGR2A-131H/H is under-represented amongst patients with primary immunodeficiencies

Flewitt EWD. et al, (2023)

The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease.

Smits B. et al, (2023), The Journal of allergy and clinical immunology, 152, 528 - 537

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK.

Shields AM. et al, (2022), Clinical and experimental immunology, 209, 247 - 258

Screening for Immunodeficiencies in Children With Invasive Pneumococcal Disease: Six-year Experience From a UK Children’s Hospital

Bijker EM. et al, (2022), Pediatric Infectious Disease Journal, 41, 575 - 578

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study.

Shields AM. et al, (2022), Journal of clinical immunology, 42, 923 - 934

Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.

Shields AM. et al, (2022), Frontiers in immunology, 13

Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.

Shields AM. et al, (2022), Frontiers in immunology, 13

A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease.

Shields AM. et al, (2020), Journal of clinical immunology, 40, 406 - 411

Implementation of a genomic medicine multi-disciplinary team approach for rare disease in the clinical setting: a prospective exome sequencing case series

Taylor J. et al, (2019), Genome Medicine, 11

Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies?

Patel S. et al, (2019), Clinical and experimental immunology, 198, 212 - 223

A comprehensive characterization of chronic norovirus infection in immunodeficient hosts.

Brown L-AK. et al, (2019), The Journal of allergy and clinical immunology, 144, 1450 - 1453

Defining B-cell defects and correlation with complications in patients with common variable immune deficiency.

Chapel H. and Patel S., (2019), The Journal of allergy and clinical immunology, 144, 654 - 655

Classical and Non-classical Presentations of Complement Factor I Deficiency: Two Contrasting Cases Diagnosed via Genetic and Genomic Methods

Shields AM. et al, (2019), Frontiers in Immunology, 10

Sequencing of human genomes with nanopore technology

Bowden R. et al, (2019), Nature Communications, 10

Load More

1
2
3
4
5